-
The U.S. Food and Drug Administration today granted accelerated approval to Vitrakvi (larotrectinib), a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker). This is […]
Nov 26,2018
-
New centers give study near complete coverage of North American FPC sites in drive to validate IMMrayTM PanCan-d, the first blood based test for early detection of pancreatic cancer — […]
Nov 13,2018
-
Cancer cells are often described as cells “gone bad” or “renegade.” New research reveals that in some of the deadliest cases of pancreatic cancer, these rebellious cells have an unexpected […]
Nov 13,2018
-
Oct 01,2021
-
There isnβt a single cause of pancreatic cancer, but rather several factorsβenvironmental or inheritedβthat can result in mutations to DNA. Genes and Pancreatic Cancer All the cells in the body […]
Sep 27,2021
-
A pancreatic cancer diagnosis affects all aspects of a patientβs life. Total patient care targets treatment and beyond, encompasses supportive measures like managing pain, getting adequate nutrition and exercise to […]
Sep 27,2021
-
Sep 27,2021
-
Sep 27,2021